Abstract
The approach to these lesions is being reexamined in light of results with conservative surgery for invasive breast cancers. According to available data, the invasive potential of in situ lesions varies. Mammographic and pathologic findings may differentiate patients who will benefit from lumpectomy (with or without radiotherapy) from those requiring mastectomy.
MeSH terms
-
Breast Neoplasms / diagnostic imaging
-
Breast Neoplasms / pathology
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / surgery
-
Breast Neoplasms / therapy*
-
Calcinosis / complications
-
Carcinoma / diagnostic imaging
-
Carcinoma / pathology
-
Carcinoma / radiotherapy
-
Carcinoma / surgery
-
Carcinoma / therapy*
-
Carcinoma in Situ / diagnostic imaging
-
Carcinoma in Situ / pathology
-
Carcinoma in Situ / radiotherapy
-
Carcinoma in Situ / surgery
-
Carcinoma in Situ / therapy*
-
Carcinoma, Intraductal, Noninfiltrating / diagnostic imaging
-
Carcinoma, Intraductal, Noninfiltrating / pathology
-
Carcinoma, Intraductal, Noninfiltrating / radiotherapy
-
Carcinoma, Intraductal, Noninfiltrating / surgery
-
Carcinoma, Intraductal, Noninfiltrating / therapy*
-
Combined Modality Therapy
-
Female
-
Humans
-
Lymph Node Excision
-
Mammography
-
Mastectomy
-
Patient Care Team*
-
Prognosis